CN1089155A - " Tiansuijianguling " of treatment osteoporosis - Google Patents

" Tiansuijianguling " of treatment osteoporosis Download PDF

Info

Publication number
CN1089155A
CN1089155A CN 93100734 CN93100734A CN1089155A CN 1089155 A CN1089155 A CN 1089155A CN 93100734 CN93100734 CN 93100734 CN 93100734 A CN93100734 A CN 93100734A CN 1089155 A CN1089155 A CN 1089155A
Authority
CN
China
Prior art keywords
rhizoma
treatment
tiansuijianguling
osteoporosis
radix
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN 93100734
Other languages
Chinese (zh)
Inventor
张金生
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN 93100734 priority Critical patent/CN1089155A/en
Publication of CN1089155A publication Critical patent/CN1089155A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The Tiansuijianguling of treatment osteoporosis belongs to the clinical new drug of orthopaedics.The present invention is made up of Radix Dipsaci, Radix Rehmanniae Preparata, Rhizoma Dioscoreae, Fructus Corni, Carapax et Plastrum Testudinis, Rhizoma Drynariae, Cornu Cervi Pantotrichum, Fructus Mori, Rhizoma Polygonati, Rhizoma Chuanxiong, Radix Angelicae Sinensis ten Herba indigoferae Pseudotinctoriae, all medicines share have nourishing YIN for suppressing the hyperactive YANG, the function of invigorating the spleen and replenishing QI, the kidney invigorating and essence nourishing, Tiansuijianguling, and can reach the activity hormone, the activation vitamin D, the purpose of enhancing bone density.This medicine manufacture method is simple, taking convenience, and good effect has no side effect, and is applicable to the treatment of middle-aged and senile osteoporosis, also is applicable to the treatment of aseptic necrosis of femoral head and delayed union of fracture.

Description

" Tiansuijianguling " of treatment osteoporosis
The invention belongs to the clinical new drug of orthopaedics
To be that a kind of person in middle and old age are multiple drop to main worldwide disease with bone mineral content to osteoporosis, its pathogenic factor is owing to person in middle and old age's asthenia of renal qi, sex hormones secretion reduce, cause bone metabolism disturbance, osteoporosis appears, it can cause that not only lumbago and backache also very easily causes the fracture at each position of whole body, quickens people's aging.It is reported that human body beginning in 30 years old bone mineral content is lost with annual 1% speed, descend 30% to 60 years old bone ore deposit.
At present domestic and international also not good therapy is used for the treatment of primary disease.Though some hospitals adopt gonadotherapy treatment osteoporosis, act on because of this therapy has certain paying, and curative effect is not ideal enough, therefore can not be as the routine treatment prolonged application; Also have part hospital application calcium preparation therapy, but can not fundamentally treat osteoporosis.More hospital then feels simply helpless to the treatment of primary disease.
Task of the present invention provides a kind of ideal medicament of fundamentally treating osteoporosis.By medication treatment, the activity hormone, the activation vitamin D, thus bone density is increased, osteoporosis obtains medical treatment.Advantages such as this medical instrument has taking convenience, and therapeutic effect is good, and is without any side effects.
The prescription of this medicine is formed: Radix Dipsaci (5~20g), Radix Rehmanniae Preparata (5~30g), Rhizoma Dioscoreae (5~15g), Fructus Corni (5~15g), Carapax et Plastrum Testudinis (5~15g), Rhizoma Drynariae (5~20g), Cornu Cervi Pantotrichum (1~3g), Fructus Mori (5~20g), Rhizoma Polygonati (5~20g), Rhizoma Chuanxiong (5~15g), Radix Angelicae Sinensis (5~20g)
Pharmacological action further specifies to this prescription below.Radix Dipsaci: invigorating the liver and kidney, promoting the circulation of blood arteries and veins, reuniting the fractured tendons and bones; Radix Rehmanniae Preparata: nourishing the blood and yin, vital essence replenishing and marrow benifiting; Rhizoma Dioscoreae: supplementing QI and nourishing YIN, spleen reinforcing, lung, kidney; Fructus Corni: liver and kidney tonifying, the convergence astringent or styptic treatment for spontaneous sweating; Carapax et Plastrum Testudinis: nourishing YIN for suppressing the hyperactive YANG, replenishing kidney and strengthening bone, the reinforcing the heart of nourishing blood; Rhizoma Drynariae: mend bone, invigorate blood circulation, stop blooding, treat bone and wither; Cornu Cervi Pantotrichum: kidney-replenishing, benefiting essence-blood, bone and muscle strengthening; Fructus Mori: nourishing YIN and supplementing blood, promote the production of body fluid, intestine moistening; Rhizoma Polygonati: lung moistening, YIN nourishing, invigorating the spleen and replenishing QI, fill out bone marrow; Rhizoma Chuanxiong: blood-activating and qi-promoting, wind-expelling pain-stopping; Radix Angelicae Sinensis: enrich blood, invigorate blood circulation, pain relieving, intestine moistening." interior warp, the big opinion of YIN YANG classification of natural phenomena " cloud: " kidney producing bone marrow, marrow occupy in the bone, and bone relies in the supplementing nutrition of marrow, the kidney essense abundance, biochemical active, then skeleton is firm tough ".As deficiency of kidney-essence, skeleton biochemistry is passive, a little less than then skeleton withers, so saying of " people cross 40 kidney qis beginning decline " arranged, illustrate that later kidney qi of middle age loses gradually, and skeleton loses the nourishing of kidney essense, so be prone to osteoporosis.The all medicines of this invention share, and play the effect of nourishing YIN for suppressing the hyperactive YANG, invigorating the spleen and replenishing QI, the kidney invigorating and essence nourishing, Tiansuijianguling altogether.Prove according to modern medicine study: osteoporosis for suffer from a deficiency of the kidney, due to the kidney hypofunction.Kidney-reinforcing drug has the activity hormone; promote the protection gonad function; promptly protect HPT-adrenal gland-gonad axis function; promote the interior activation of body of vitamin D; participate in alcium and phosphor metabolization, vitamin D is effectively utilized, the absorbtivity of calcium increases; it is calcareous that the sclerotin that impels sparse flaccidity to contract obtains in a large number replenishing, thereby reach the purpose that strengthens bone density.
During making, at first all medicine crushed after being dried are become the powder face, break into tablet then or make electuary and all can.
During use, obey 5g at every turn, whenever take medicine and checked a bone density recovery situation in one month every day three times, bone density gets final product drug withdrawal after recovering normally.
Through clinical treatment 90 routine osteoporosis patients, total effective rate can reach more than 90% at present, and medicine time, average out to was about 4 months.
This medicine manufacture method is simple, taking convenience, and therapeutic effect is good, has no side effect, and is applicable to the treatment of middle-aged and senile osteoporosis, also is applicable to the treatment of aseptic necrosis of femoral head and delayed union of fracture.
The following examples are described further the present invention:
Get Radix Rehmanniae Preparata 30g, Radix Dipsaci 20g, Rhizoma Drynariae 20g, Fructus Mori 20g, Rhizoma Polygonati 20g, Radix Angelicae Sinensis 20g, Rhizoma Dioscoreae 15g, Fructus Corni 15g, Carapax et Plastrum Testudinis 15g, Rhizoma Chuanxiong 15g, Cornu Cervi Pantotrichum 3g, be ground into face after the oven dry, sieve then, fine flour is broken into tablet or electuary, took 5g, every day three times, month medicine of every take in 30 minutes after meal at every turn, survey one time bone density, get final product drug withdrawal after bone density is normal.

Claims (1)

1, " Tiansuijianguling " of treatment osteoporosis is characterized in that prescription has Radix Dipsaci 5~20g (1), Radix Rehmanniae Preparata 5~30g (2), Rhizoma Drynariae 5~20g (3), Fructus Mori 5~20g (4) Rhizoma Polygonati 5~20g (5), Radix Angelicae Sinensis 5~20g (6), Rhizoma Dioscoreae 5~15g (7), Fructus Corni 5~15g (8), Carapax et Plastrum Testudinis 5~15g (9), Cornu Cervi Pantotrichum 1~3g (10), Rhizoma Chuanxiong 5~15g (11)
CN 93100734 1993-01-01 1993-01-01 " Tiansuijianguling " of treatment osteoporosis Pending CN1089155A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 93100734 CN1089155A (en) 1993-01-01 1993-01-01 " Tiansuijianguling " of treatment osteoporosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 93100734 CN1089155A (en) 1993-01-01 1993-01-01 " Tiansuijianguling " of treatment osteoporosis

Publications (1)

Publication Number Publication Date
CN1089155A true CN1089155A (en) 1994-07-13

Family

ID=4983196

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 93100734 Pending CN1089155A (en) 1993-01-01 1993-01-01 " Tiansuijianguling " of treatment osteoporosis

Country Status (1)

Country Link
CN (1) CN1089155A (en)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1304031C (en) * 1999-11-19 2007-03-14 李振 Chinese medicine for treating femur head necrosis
CN101380416B (en) * 2008-09-28 2010-12-08 太仓宇航人生物工程有限公司 Medicine composition for treating osteoporosis and hyperosteogeny
CN102058717A (en) * 2011-01-25 2011-05-18 郭芫沅 Chinese medicine for treating femoral head necrosis
CN101856114B (en) * 2010-05-14 2012-05-30 浙江省医学科学院 Health food with bone intensity enhancing function and preparation method thereof
CN102614339A (en) * 2011-06-07 2012-08-01 李学朋 Preparation method of Chinese patent medicine used for treating osteoporosis
CN102824583A (en) * 2012-08-27 2012-12-19 马红 Method of preparing traditional Chinese medicine lotion for treating lumbago type closed fracture
CN104435715A (en) * 2014-12-22 2015-03-25 徐晓辉 Traditional Chinese medicinal liquid for treating avascular necrosis of femoral head
CN114452353A (en) * 2022-01-10 2022-05-10 湖北民族大学 Composition for treating osteoporosis, preparation method and application thereof

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1304031C (en) * 1999-11-19 2007-03-14 李振 Chinese medicine for treating femur head necrosis
CN101380416B (en) * 2008-09-28 2010-12-08 太仓宇航人生物工程有限公司 Medicine composition for treating osteoporosis and hyperosteogeny
CN101856114B (en) * 2010-05-14 2012-05-30 浙江省医学科学院 Health food with bone intensity enhancing function and preparation method thereof
CN102058717A (en) * 2011-01-25 2011-05-18 郭芫沅 Chinese medicine for treating femoral head necrosis
CN102058717B (en) * 2011-01-25 2012-01-25 郭芫沅 Chinese medicine for treating femoral head necrosis
CN102614339A (en) * 2011-06-07 2012-08-01 李学朋 Preparation method of Chinese patent medicine used for treating osteoporosis
CN102824583A (en) * 2012-08-27 2012-12-19 马红 Method of preparing traditional Chinese medicine lotion for treating lumbago type closed fracture
CN102824583B (en) * 2012-08-27 2014-01-15 吕顺玲 Method of preparing traditional Chinese medicine lotion for treating lumbago type closed fracture
CN104435715A (en) * 2014-12-22 2015-03-25 徐晓辉 Traditional Chinese medicinal liquid for treating avascular necrosis of femoral head
CN114452353A (en) * 2022-01-10 2022-05-10 湖北民族大学 Composition for treating osteoporosis, preparation method and application thereof

Similar Documents

Publication Publication Date Title
CN102872299B (en) Medicine compound for treating osteoporosis and osteoporosis fracture
CN102078482B (en) Traditional Chinese medicine combination for treating bone injury and fracture and preparation method of the same
CN101112445A (en) Chinese traditional medicine prescription for treating osteoporosis
CN102319332B (en) Musk bone reunion Chinese medicinal composition
CN103110762A (en) Traditional Chinese medicine composition for treating old fracture
CN102697967A (en) Tablet for blacking hair, benefiting brains and nourishing liver and kidney
CN103127326A (en) Pharmaceutical composition for treating osteoarthritis and preparation method thereof
CN1089155A (en) " Tiansuijianguling " of treatment osteoporosis
CN1129130A (en) Medicament for treatment of cervical spondylopathy
CN111298019B (en) Traditional Chinese medicine for treating tachyarrhythmia
CN101843690B (en) Chinese medicament for treating osteoporosis
CN1324650A (en) Effective medicine for treating cervical vertebra disease as one kind of intractable disease
CN106491971A (en) A kind of for treating Chinese medicine composition of pulpitiss and preparation method thereof
CN101862398B (en) Chinese medicament for treating osteoporosis
CN101537114B (en) Chinese medicine for treating arrhythmia
CN1087619C (en) Medicines for treating osteoporosis and their preparing process
CN102552744A (en) Traditional Chinese medicinal preparation for treating common nerve compression syndrome in loin cavity caused by hyperosteogeny
CN103055085B (en) Traditional Chinese medical preparation for treating iron-deficiency anemia
CN101732648B (en) Medicament for treating nonunion
CN1232272C (en) Haigou shenlong pill
CN1115162C (en) Pure traditional Chinese medicine for treating hyperosteogeny and preparation process thereof
CN105796860A (en) Quick-acting bone setting Yi medicine
CN104587394A (en) Traditional Chinese medicine composition for treating delayed union and nonunion
CN105055921A (en) Traditional Chinese medicine preparation for treating psychoneuroses
CN103877201B (en) A kind of pharmaceutical composition and application thereof for the treatment of senile osteoporosis lumbago and backache

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication